Fast-track Medical Device Rules for Emergencies

Summary#

The federal government has made final changes called the Regulations Amending the Medical Devices Regulations (Medical Devices for an Urgent Public Health Need). The changes let Health Canada use a permanent, faster authorization route in future public‑health emergencies (not just COVID‑19). The amendments came into force on January 3, 2024.

What it does#

• Broadens Part 1.1 of the Medical Devices Regulations so the same fast‑track pathway used for COVID‑19 devices can apply to other medical conditions that present a significant public‑health risk and need immediate action.
• Lets the Minister add medical conditions and specific devices (or categories of devices) to a published list called the List of Medical Devices for an Urgent Public Health Need (the UPHN list).
• Keeps the faster rules optional. Manufacturers can still use the regular Part 1 pathway instead.
• Allows applications that are already in the system to be finished even if the UPHN list changes before a decision is made.
• Adds or clarifies post‑market and reporting rules:
  • Authorization holders must notify the Minister within 72 hours if they learn a foreign regulator suspended or revoked the device’s approval.
  • Importers must ensure shipments of authorized devices are accompanied by a copy of the authorization.
  • Manufacturers must send a new or updated quality management certificate to the Minister within 30 days after it is issued (for certain devices).
• Tightens rules about changing what a device is used for:
  • Class I device holders must apply to amend their authorization if they change the device’s medical conditions, purposes, or uses.
  • The Minister may refuse an amendment that would remove the device’s connection to any UPHN medical condition that qualified it for authorization.
• Restricts advertising of Class I devices that are undergoing a change unless the authorization is amended — or the ad appears only in a catalogue with a clear warning.
• Keeps a transition and sell‑off window: if an authorization is cancelled, other sellers may continue to sell the device for six months to clear stock.
• Removes COVID‑19‑specific wording so the pathway can be used for other emergencies.

Who's affected#

• Health Canada (as regulator) — for managing and reviewing applications and enforcement.
• Manufacturers and authorization holders of medical devices, including those with existing COVID‑19 authorizations now carried over into the amended rules.
• Importers and distributors, who must carry authorizations with shipments and may be responsible for some reporting.
• Small businesses that make or sell medical devices: they may use a quicker route in an emergency but could face new steps if a device’s status changes.
• Health‑care providers and patients indirectly, because the rule affects how quickly devices for urgent needs can reach Canada.
• Foreign regulatory agencies are referenced because their suspensions or revocations can trigger Canadian reporting requirements.

If it is unclear who will be affected in specific cases, the regulation leaves room for the Minister to decide which medical conditions and devices are covered.

Why it matters#

• It creates a permanent, predictable way to speed up access to medical devices during future public‑health emergencies.
• That can mean faster availability of diagnostics, protective equipment, treatments or other devices needed to respond to sudden health risks.
• It balances faster access with safety checks by keeping post‑market reporting, authorizations, and possible conditions on approvals.
• Businesses gain a stable pathway instead of relying on short‑term interim orders, but some manufacturers may face extra steps if their device’s authorized uses change.
• Overall, the change is meant to make Canada better prepared to get critical medical devices into the system quickly while keeping oversight in place.